Binimetinib Intermediate 4

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Binimetinib Intermediate 4 is a late-stage intermediate in the synthesis of Binimetinib. It contains the key functional groups needed for the final drug structure and is crucial for process optimization, ensuring purity, and achieving the desired pharmacological activity targeting the MAPK/ERK signaling pathway.

Head Office Address

Our Office Addresses